Recent approaches to the management and prevention of respiratory syncytial virus infection.
University of Vermont, Burlington, USA.
C A
CA
McCarthy
C B
CB
Hall
D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control* / Q000821:virology; D012136:Respiratory Syncytial Viruses / Q000502:physiology; D012254:Ribavirin / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use
D000998:Antiviral Agents; D014765:Viral Vaccines; D012254:Ribavirin